PT1567137E - Utilização de resveratrol para a preparação de um medicamento útil para o tratamento de infecções por vírus da influenza - Google Patents

Utilização de resveratrol para a preparação de um medicamento útil para o tratamento de infecções por vírus da influenza Download PDF

Info

Publication number
PT1567137E
PT1567137E PT03772659T PT03772659T PT1567137E PT 1567137 E PT1567137 E PT 1567137E PT 03772659 T PT03772659 T PT 03772659T PT 03772659 T PT03772659 T PT 03772659T PT 1567137 E PT1567137 E PT 1567137E
Authority
PT
Portugal
Prior art keywords
resveratrol
virus
cells
viral
infection
Prior art date
Application number
PT03772659T
Other languages
English (en)
Portuguese (pt)
Inventor
Enrico Garaci
Anna T Palamara
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1567137E publication Critical patent/PT1567137E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT03772659T 2002-11-06 2003-10-14 Utilização de resveratrol para a preparação de um medicamento útil para o tratamento de infecções por vírus da influenza PT1567137E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Publications (1)

Publication Number Publication Date
PT1567137E true PT1567137E (pt) 2008-02-19

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03772659T PT1567137E (pt) 2002-11-06 2003-10-14 Utilização de resveratrol para a preparação de um medicamento útil para o tratamento de infecções por vírus da influenza

Country Status (18)

Country Link
US (1) US8431617B2 (enExample)
EP (1) EP1567137B1 (enExample)
JP (1) JP4589118B2 (enExample)
KR (1) KR101060331B1 (enExample)
AR (1) AR041891A1 (enExample)
AT (1) ATE381929T1 (enExample)
AU (1) AU2003279551A1 (enExample)
CA (1) CA2504872C (enExample)
CY (1) CY1107302T1 (enExample)
DE (1) DE60318327T2 (enExample)
DK (1) DK1567137T3 (enExample)
ES (1) ES2295660T3 (enExample)
IT (1) ITRM20020562A1 (enExample)
MX (1) MXPA05004628A (enExample)
PL (1) PL217628B1 (enExample)
PT (1) PT1567137E (enExample)
TW (1) TWI337863B (enExample)
WO (1) WO2004041260A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2626056A1 (en) * 2005-11-18 2007-05-24 Ares Trading S.A. Interferon in influenza
US8629283B2 (en) * 2008-03-06 2014-01-14 Icahn School Of Medicine At Mount Sinai Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof
AU2009313657A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating AMP-kinase
WO2010123527A2 (en) * 2008-12-19 2010-10-28 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
US9096585B2 (en) 2010-05-28 2015-08-04 Icahn School Of Medicine At Mount Sinai Antiviral compounds and uses thereof
US9453017B2 (en) * 2011-09-30 2016-09-27 Vanderbilt University Antiviral therapies with phospholipase D inhibitors
PT2952209T (pt) 2014-06-04 2018-05-09 Alfasigma Spa Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral
SI2952180T1 (sl) 2014-06-04 2017-05-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Trdne formulacije, ki vsebujejo resveratrol in polinenasičene maščobne kisline omega-3 (n-3 PUFA)
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
EP4132277B1 (en) * 2020-04-05 2025-11-26 Mong, Michael Systems and methods for treating coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
DE60015568D1 (de) * 1999-08-13 2004-12-09 Univ Maryland Biotech Inst Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür

Also Published As

Publication number Publication date
JP4589118B2 (ja) 2010-12-01
DE60318327T2 (de) 2008-12-18
JP2006507295A (ja) 2006-03-02
AR041891A1 (es) 2005-06-01
PL377557A1 (pl) 2006-02-06
CA2504872A1 (en) 2004-05-21
TWI337863B (en) 2011-03-01
AU2003279551A1 (en) 2004-06-07
EP1567137B1 (en) 2007-12-26
EP1567137A1 (en) 2005-08-31
PL217628B1 (pl) 2014-08-29
TW200501935A (en) 2005-01-16
DK1567137T3 (da) 2008-04-28
WO2004041260A1 (en) 2004-05-21
ITRM20020562A1 (it) 2004-05-07
US20050239906A1 (en) 2005-10-27
US8431617B2 (en) 2013-04-30
CA2504872C (en) 2011-07-05
DE60318327D1 (de) 2008-02-07
MXPA05004628A (es) 2005-09-08
ATE381929T1 (de) 2008-01-15
ES2295660T3 (es) 2008-04-16
KR101060331B1 (ko) 2011-08-30
CY1107302T1 (el) 2012-11-21
KR20050071627A (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
RU2769317C2 (ru) Способы лечения гриппа
PT1567137E (pt) Utilização de resveratrol para a preparação de um medicamento útil para o tratamento de infecções por vírus da influenza
JP6952379B2 (ja) 急性ウイルス性呼吸器疾患を治療するための経鼻医薬組成物
KR102233826B1 (ko) 바이러스 감염을 치료하기 위한 티아졸리드 화합물
JP2008523153A (ja) 疾病の伝染を減少させる組成物及び方法
CA2871774A1 (en) Use of n-acetylcysteine amide in the treatment of disease and injury
US20110129446A1 (en) Clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
US20200054595A1 (en) EGCG-Palmitate Compositions and Methods of Use Thereof
Hayden Combinations of antiviral agents for treatment of influenza virus infections
WO2017083971A1 (en) Compositions and methods for treatment of influenza
ES2937145T3 (es) Azelastina como tratamiento antiviral
Tagaya et al. Inhibition of vesicle-mediated protein transport by nordihydroguaiaretic acid
WO2021191904A1 (en) Methods for preventing and treating viral infection
CN101884651A (zh) 山香圆叶水提取物及其制备方法和用途
US11197912B2 (en) Prevention and treatment of viral infection and viral infection-induced organ failure
RU2543338C1 (ru) Лечебно-профилактическое средство против вируса натуральной оспы и способы его получения и применения
US20230248680A1 (en) Use of rigosertib to treat rna virus infections
Sharti et al. Double-Stranded RNA Activated Caspase Oligomerizer (DRACO): Design, Subcloning, and Antiviral Investigation
KR20030014556A (ko) 신규 항바이러스제
CN105920004B (zh) 1，2，4-三取代哌嗪化合物在制备抗流感病毒药物中的用途
RU2414235C1 (ru) ПРИМЕНЕНИЕ ПЕПТИДА Arg-Pro-Gly-Pro В КАЧЕСТВЕ ПРОТИВОВИРУСНОГО СРЕДСТВА ДЛЯ ЖИВОТНЫХ
CN104027349A (zh) 泊洛沙姆188在制备预防和/或治疗帕金森症的药物中的应用
ES2918021A1 (es) extracto de una planta de Marchantia y de polymorpha subsp. y sus usos
ES2586505A1 (es) Análogos de ferruginol como agentes antivirales